Keys AM, Kastner DW, Kiessling LL, Kulik HJ. CH-Ï€ interactions confer orientational flexibility in protein-carbohydrate binding sites. The Journal of biological chemistry. 2025;301(8):110379. doi:10.1016/j.jbc.2025.110379
Publications
Kim MS, Khurshid S, Kany S, et al. Machine Learning-Based Plasma Protein Risk Score Improves Atrial Fibrillation Prediction Over Clinical and Genomic Models. Circulation. Genomic and precision medicine. 2025;18(4):e004943. doi:10.1161/CIRCGEN.124.004943
Ford JG, Koh MJ, Lenart AW, et al. Real-world evidence of duvelisib and romidepsin in relapsed/refractory peripheral and cutaneous T-cell lymphomas. Blood advances. 2025;9(16):4286-4305. doi:10.1182/bloodadvances.2025016347
Ochoa-Guzmán A, Tusié-Luna MT, Chiquete E, Medina-GarcÃa A, Huerta-Chagoya A. The genetics of the most prevalent metabolic diseases in Mexicans. Gaceta medica de Mexico. 2025;161(1):9-17. doi:10.24875/GMM.M25000983
Nguyen VK, Zimmerman S, Colacino J, Jolliet O, Patel CJ. Body dissatisfaction widens the racial disparities of Benzophenone-3, a chemical biomarker of personal care and consumer product usage. Environment international. 2025;202:109557. doi:10.1016/j.envint.2025.109557
Yagi M, Bonilla G, Hoetker MS, et al. Bivalent chromatin instructs lineage specification during hematopoiesis. Cell. 2025;188(16):4314-4331.e29. doi:10.1016/j.cell.2025.05.011
Hlushchenko I, Pamilo S, Islam MM, et al. Linking Variability of Leukocyte Lipid Metabolism to Circulating Lipids, Lipoprotein Composition, and Cardiovascular Risk in the Finnish Adult Population. Arteriosclerosis, thrombosis, and vascular biology. 2025;45(8):1416-1431. doi:10.1161/ATVBAHA.125.322801
Tak D, Garomsa BA, Zapaishchykova A, et al. Longitudinal Risk Prediction for Pediatric Glioma with Temporal Deep Learning. NEJM AI. 2025;2(5). doi:10.1056/aioa2400703
Horisberger A, Griffith A, Keegan J, et al. Blood immunophenotyping identifies distinct kidney histopathology and outcomes in patients with lupus nephritis. The Journal of clinical investigation. 2025;135(16). doi:10.1172/JCI181034
Graser C, McDonald TO, Catalano PJ, Sonpavde G, Michor F. Response to: Correspondence on "Early dynamics of clinical and laboratory parameters predict primary refractory disease in patients with metastatic urothelial carcinoma receiving atezolizumab" by Gao . Journal for immunotherapy of cancer. 2025;13(6). doi:10.1136/jitc-2025-012742